RARA and neoplasm: Furthermore, Epping et al. reported that the retinoic acid receptor (RAR) pathway is targeted by HDAC inhibitor and that the antitumor effect of HDAC inhibitor in tumor cells is, in part, through derepression of retinoic acid [48].